Multiple Cannabis Use Methods Mark a Higher-Risk Pattern
A national analysis of U.S. adults points to a warning sign that is easy to miss in routine clinical conversations: using cannabis in multiple forms may be associated with a much heavier pattern of use and a substantially greater likelihood of cannabis use disorder. Among adults who had used cannabis in the preceding month, researchers identified four distinct consumption patterns, and the group that used cannabis in nearly every available form stood apart from the rest. Roughly one in seven users fell into this polymodal category, a finding that matters because product choice is no longer limited to smoked plant material.
The study drew on 17,732 adults from the 2022-2023 National Survey on Drug Use and Health and used statistical methods to sort people into groups with similar consumption habits. Nearly half primarily smoked cannabis, 21% combined smoking and vaping, 17% mainly used edibles, and 14% used cannabis across almost every route, including smoking, vaping, edibles, and dabbing. The key clinical message is not simply that people vary in how they consume cannabis. It is that those variations cluster with very different addiction profiles.
Daily use followed the same gradient. About half of the polymodal group used cannabis every day, compared with 28% of those who primarily smoked, 31% of those who smoked and vaped, and about 13% of those who mainly used edibles. In a condition where frequency itself is often a proxy for loss of control, that pattern is difficult to ignore. Heavy exposure across several formulations may signal a user who is not just experimenting with product variety but reinforcing use through multiple behavioral and pharmacologic cues.
The clearest divergence appeared in diagnostic criteria for cannabis use disorder. Nearly 67% of polymodal users met criteria for the disorder, versus 47% of people who smoked and vaped, 36% of those who mainly smoked, and 15% of those who mainly used edibles. Such a wide separation suggests that route of administration may be more than a preference variable. It may reflect depth of exposure, higher tolerance, more frequent cue-driven use, or a broader pattern of substance-related vulnerability.
Daily Use and Disorder Rates Track With Route of Administration
The clinical implications are immediate for primary care, psychiatry, emergency medicine, and adolescent health. When a patient answers yes to cannabis use, the next question should not stop at quantity or frequency. Asking how the drug is used can reveal whether the patient is relying on a single route or cycling among several products, a distinction that may justify a fuller assessment for compulsive use, escalating tolerance, and functional impairment.
Omar El-Shahawy, MD, PhD, MPH, and colleagues argue that multiple-method use may function as a red flag for heavier use. That interpretation fits the observed pattern, especially because nearly one-third of both the smoking and vaping group and the polymodal group were young adults ages 18 to 25. Only about one sixth of those who primarily smoked fell into that age bracket. Younger users may be more willing to sample concentrates, vape products, edibles, and smoked forms in parallel, creating a broader exposure pattern that can normalize frequent use.
Edibles stood out in another direction. Women made up more than half of people who mainly consumed edible cannabis products, and this method was particularly common among college graduates. The study did not test why those preferences emerged, so the motivations remain uncertain. Some users may be seeking discretion, avoiding inhalation, or choosing products for perceived medical benefits. Others may be using edibles because they fit into work, parenting, or social routines more easily than smoking or vaping. The study does not resolve those motivations, but it does show that edible use is not merely a softer version of smoking; it sits in a distinct demographic and behavioral cluster.
The mechanism behind the association between multiple forms of use and addiction symptoms is not proven here, yet the biology is plausible. Repeated exposure through different delivery systems can change the pace and intensity of drug effect. Smoking and vaping deliver cannabinoids quickly, reinforcing reward pathways rapidly, while edibles have delayed onset and can encourage redosing before the full effect appears. A person who alternates among these methods may be chasing both immediacy and duration, a combination that can promote more frequent use and make self-regulation harder.
Smoking, Combustion, and a Broader Toxic Exposure Burden
The inhaled route brings a separate concern. People who smoked cannabis were more likely to also smoke cigarettes than those who mainly vaped or used edibles. Because both tobacco and cannabis smoking rely on combustion, this subgroup may be inhaling a wider mixture of harmful chemicals. Joseph J. Palamar, PhD, MPH, described that overlap as worrisome because the lungs are exposed to a larger combustion burden. For clinicians, the point is practical: a patient who smokes both substances may face additive pulmonary harm even before addiction severity is considered.
Public health messaging has lagged behind the way people actually use cannabis. Education campaigns still center heavily on smoking, yet the modern user may be vaping concentrates, swallowing edibles, dabbing, or shifting among all four. The study supports a more tailored approach. For younger adults, counseling should include the risks of vaping and using several forms at once. For edible users, the familiar advice to start low and go slow remains important because delayed effects can lead to overconsumption before intoxication is fully apparent.
The findings also carry a screening lesson. A clinician who asks only whether a patient uses cannabis may miss the signal embedded in method selection. A person using several formulations may warrant closer attention even if individual products appear low risk in isolation. The association between polymodal use and disorder was strong enough to justify that extra step.
Still, the study stops short of proving causation. Self-reported cannabis habits may be incomplete or inaccurate, and an observational design cannot show that using multiple forms directly causes addiction. The data establish association, not mechanism. They also leave open an important question: whether some people gravitate to edibles because they are trying to manage pain, insomnia, or another symptom, rather than because they are more prone to addiction. Future work will need to separate symptom-driven use from escalating nonmedical use, and to determine whether method switching is an early marker of worsening dependence or simply a correlate of it.